Search Results 361-370 of 17010 for pharmacogenetics
Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...
The aim is to develop and implement a laboratory test designed to assess the viability of isolated cancer cells when exposed to various chemotherapy drug ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Social Determinants Of Migrant Health Factors Impacting Prostate Cancer Care And Survivorship Among Sub-Saharan African And Caribbean Immigrant Men · Overview.
The purpose of the study is to find specific and sensitive RNA markers that not only describe the underlying inflammatory process, but can help direct therapy ...
View faculty and staff of Mayo Clinic's Epigenetic Etiology of Human Disease Lab led by Keith D. Robertson, Ph.D.
The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...
Mayo Clinic's High-Dimensional Phenotyping Lab is a translational research & innovation lab that seeks to understand physiology at scale & deploy rigorous, ...
Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c. 388A>G Variant Is Determinant of Increased Atorvastatin Response Int J Mol Sci. 2011; 12(9): ...
The overall goal of this research is to investigate potential differences in the regulation of skin blood flow in individuals with spinal cord injury.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.